Difficulty: Medium
Average Score: 80%
Practice
Which statement about thiopentone is true?
Correct answer
D
Rationale
In the context of CNS stimulants drugs pharmacology, understanding the pharmacokinetics and pharmacodynamics of thiopentone is crucial for safe and effective clinical practice. The correct answer, option D, states that thiopentone's anesthetic action is terminated by redistribution from the central nervous system (CNS) to other highly vascularized tissues. This statement is true because thiopentone, a barbiturate, is known for its rapid redistribution from the brain to peripheral tissues, leading to a short duration of action despite its initial fast onset.
Option A, stating that thiopentone is not lipid-soluble, is incorrect. Thiopentone is highly lipid-soluble, which allows it to cross the blood-brain barrier quickly and exert its anesthetic effects in the CNS. Option B, suggesting that thiopentone can be used intramuscularly (IM) or intravenously (IV) to induce anesthesia, is incorrect. Thiopentone is typically administered intravenously due to its irritant properties and the need for precise dosing and rapid onset.
Option C, claiming that thiopentone has good analgesic properties, is also incorrect. Thiopentone is primarily used as an intravenous anesthetic agent and is not a potent analgesic. It acts mainly as a sedative-hypnotic agent to induce anesthesia rather than providing significant analgesia.
Educationally, understanding the pharmacological properties of thiopentone is essential for healthcare professionals involved in anesthesia administration. Knowing that thiopentone's anesthetic effects are short-lived due to redistribution helps in managing its dosing regimen and potential side effects. This knowledge contributes to safe anesthetic practices and optimal patient care in clinical settings.
Option A, stating that thiopentone is not lipid-soluble, is incorrect. Thiopentone is highly lipid-soluble, which allows it to cross the blood-brain barrier quickly and exert its anesthetic effects in the CNS. Option B, suggesting that thiopentone can be used intramuscularly (IM) or intravenously (IV) to induce anesthesia, is incorrect. Thiopentone is typically administered intravenously due to its irritant properties and the need for precise dosing and rapid onset.
Option C, claiming that thiopentone has good analgesic properties, is also incorrect. Thiopentone is primarily used as an intravenous anesthetic agent and is not a potent analgesic. It acts mainly as a sedative-hypnotic agent to induce anesthesia rather than providing significant analgesia.
Educationally, understanding the pharmacological properties of thiopentone is essential for healthcare professionals involved in anesthesia administration. Knowing that thiopentone's anesthetic effects are short-lived due to redistribution helps in managing its dosing regimen and potential side effects. This knowledge contributes to safe anesthetic practices and optimal patient care in clinical settings.